Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR | Market Cap | 46.15B +81.5% |
| Revenue (ttm) | 19.51B +9.5% |
| Net Income | 1.41B +51.8% |
| EPS | 2.55 +49.7% |
| Shares Out | 547.95M |
| PE Ratio | 33.02 |
| Forward PE | n/a |
| Dividend | 0.20 (0.24%) |
| Ex-Dividend Date | Sep 18, 2026 |
| Volume | 2,993,998 |
| Open | 84.67 |
| Previous Close | 84.22 |
| Day's Range | 83.16 - 90.41 |
| 52-Week Range | 33.44 - 90.41 |
| Beta | 0.77 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 4, 2026 |
About Morepen Laboratories
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethosco... [Read more]
Financial Performance
In fiscal year 2026, Morepen Laboratories's revenue was 18.06 billion, a decrease of -0.32% compared to the previous year's 18.12 billion. Earnings were 948.77 million, a decrease of -19.61%.
Financial StatementsNews
Morepen Laboratories announces resignation of senior management personnel Bhola Prasad
Morepen Laboratories Limited has announced the resignation of Mr. Bhola Prasad, who served as the General Manager of Process Engineering & Technology Transfer. Mr. Prasad, a key figure in the…
Morepen Laboratories shares surge over 4% as company begins commercial supplies under Rs 825 crore CDMO Mandate
Morepen Laboratories shares surged more than 4% in early trade on Wednesday after the company announced the commencement of commercial supplies under its ₹825 crore Contract Development and Manufactur...
Morepen Laboratories completes first ₹50 crore dispatch under ₹825 crore CDMO mandate
Morepen Laboratories Limited has begun commercial supplies under its ₹825 crore CDMO mandate, marking a significant milestone. The company completed its first commercial dispatch valued at approximate...
Morepen Laboratories shares rally sharply over 13% today: Details here
Morepen Laboratories shares surged sharply by over 13% in intraday trade on Tuesday, June 9, as strong buying interest and robust trading volumes lifted the stock to its highest level…
Why are Morepen Lab shares falling sharply over 5% today? Explained
Shares of Morepen Laboratories fell sharply over 5% in early trade on May 27 after the company reported subdued fourth-quarter earnings, weighed down by a sharp decline in operating profit…
Morepen Labs Q4 net profit surges 69% as CDMO programme enters commercial phase
Morepen Laboratories Limited has reported a robust performance for the fourth quarter of FY26, with net profit soaring by 69% year-on-year to ₹20 crore and gross revenue climbing 22% to…
Morepen Laboratories appoints Vipul Kumar Srivastava as Company Secretary
Morepen Laboratories has appointed Vipul Kumar Srivastava as Company Secretary, according to a regulatory filing submitted to the National Stock Exchange of India (NSE). The appointment was formalised...
Morepen Laboratories secures Rs 30 crore term loan from Shinhan Bank
Morepen Laboratories has announced that its Finance Committee has approved a significant financial arrangement with Shinhan Bank. The company secured an unsecured term loan facility amounting to ₹30 c...
Morepen Labs gets US FDA clearance with 0 observations for Himachal unit, 4th straight nod with 0 observations
Morepen Laboratories Limited has successfully completed a United States Food and Drug Administration (USFDA) inspection at its Masulkhana facility in Himachal Pradesh, with zero observations, marking ...
Morepen Laboratories repays Rs 99 crore credit facility to Kotak Mahindra Bank
Morepen Laboratories has fully repaid a credit facility totalling ₹99 crore to Kotak Mahindra Bank as of 2 March 2026. The credit facility included a working capital demand loan of…
Pharma sector stocks down today, March 2: Morepen Lab falls 3.24%, Ajanta Pharma drops 2.32%, Natco Pharma down 2.26%
The Indian pharmaceutical sector experienced a sharp decline on March 2, 2026, with many stocks trading lower in early sessions....
Morepen Laboratories shares surge nearly 15% today after Rs 825 crore global CDMO deal, up 30% in two days
Shares of Morepen Laboratories jumped 14.99% to close at Rs 45.11 on the NSE on February 23, gaining Rs 5.88...
Pharma sector stocks today, Feb 23: Morepen Labs up 13.92%, Cohance Lifesciences jumps 4.37%, EMCURE Pharma down 3%
The pharmaceutical sector in India showed modest gains in early trading on February 23, 2026. The S&P BSE HEALTHCARE Index...
Morepen Laboratories shares jump nearly 10% after Rs 825 crore global CDMO deal
Shares of Morepen Laboratories Ltd surged nearly 10% in Monday’s trade after the company announced a multi-year global mandate worth...
Pharma sector stocks today, Jan 28: RPG Life falls 8.88%, Sun Pharma down 1.14%, Morepen Labs up to 2.98%
The Indian pharmaceutical sector showed mixed performance on January 28, 2026, as of around 10:13 AM IST. Broader market indices...
Morepen Laboratories receives GST show-cause notice alleging excess refund claim of ₹117.94 crore
Morepen Laboratories Ltd has disclosed that it has received a show-cause notice from the Office of the Commissioner, Central GST...
Morepen Laboratories secures Rs 50 crore unsecured term loan from Kookmin Bank
Morepen Laboratories Limited, in a regulatory filing on Monday, November 10, 2025, announced that its Finance Committee has approved an...
Morepen Laboratories shares rally over 4% after company forms 50:50 Joint Venture with UAE’s Bimedical FZE
Morepen Laboratories’ stock gained more than 4% in early trade after the company announced a new strategic partnership in the medical devices space. Its subsidiary, Morepen Medipath Limited (formerly ...
Morepen Laboratories subsidiary to form 50:50 JV with UAE’s Bimedical FZE for medical devices business
Morepen Laboratories Limited has announced that its subsidiary, Morepen Medipath Limited (formerly Morepen Medtech Limited), has signed a joint venture agreement with Bimedical FZE, a UAE-based entity...
Morepen Laboratories shares drop 4% as Q1 net profit drops 68.5% YoY to Rs 11.4 crore
Shares of Morepen Laboratories fell 4% on August 6 after the company reported a sharp decline in its financial performance for the first quarter of FY26. The stock opened at ₹57.20 but slipped to a lo...
Morepen Laboratories Q1 Results: Net profit plunges 68% YoY to Rs 11.4 crore, revenue down 6.6% YoY
Morepen Laboratories reported a weak set of numbers for the first quarter of FY26, with sharp year-on-year declines across all key financial metrics. The company’s net profit slumped 68.5% to ₹11.4 cr...
Morepen Laboratories secures Rs 50 crore loan facility from Qatar National Bank
Morepen Laboratories Limited has announced that its Board of Directors has approved a financial agreement with Qatar National Bank for a loan facility totalling ₹50 crore. The arrangement, finalized o...
Morepen Laboratories share price drops 3% as Q4 Ebitda falls 12.6% to Rs 42.3 crore
Shares of Morepen Laboratories fell 3% in early trade on Monday after the company released its consolidated financial results for the fourth quarter of the financial year 2024-25 (Q4 FY25). The market...
Morepen Laboratories receives SEC clearance for Resmetirom bioequivalence studies
Morepen Laboratories Ltd. has received clearance from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) to conduct bioequivalence (BE) studies for Resmetiro...
Morepen Labs shares rally 7% today on this major update – Know More
Shares of Morepen Laboratories Ltd. surged over 7% to ₹58.35 on the NSE in Thursday’s trade following the announcement of four major product launches across critical therapeutic segments. The stock op...